Despite Blocking Doxorubicin-Induced Vascular Damage, Quercetin Ameliorates Its Antibreast Cancer Activity

Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism

(2020) Hanan A. Bashmail et al.   MOLECULES

Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome

(2020) Osama A. A. Ahmed et al.   Scientific Reports

Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines

(2019) Helen M. Palethorpe et al.   MOLECULES

Arginase overexpression and NADPH oxidase stimulation underlie impaired vasodilation induced by advanced glycation end products

(2018) Hany M. El-Bassossy et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anticancer Profiling for Coumarins and Related O-Naphthoquinones from Mansonia gagei against Solid Tumor Cells In Vitro

(2018) Mohammed Baghdadi et al.   MOLECULES

Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products

(2018) Jie Yu et al.   PHYTOMEDICINE

Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities

(2018) Hanan A. Bashmail et al.   Scientific Reports

New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines

(2017) Gamal A. Mohamed et al.   JOURNAL OF ETHNOPHARMACOLOGY

Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel

(2017) Moustafa E. El-Araby et al.   PLoS One

Cell-in-Cell Death Is Not Restricted by Caspase-3 Deficiency in MCF-7 Cells

(2016) Shan Wang et al.   Journal of Breast Cancer

Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect

(2016) Hany M. El-Bassossy et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity

(2016) Fahad Al-Abbasi et al.   MOLECULES

Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity

(2016) Sahar A. Khaleel et al.   Scientific Reports

Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis

(2016) Shikha Srivastava et al.   Scientific Reports

P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review

(2015) Hossam M. Abdallah et al.   Journal of Advanced Research

Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression

(2014) Qinghua Dong et al.   BRITISH JOURNAL OF PHARMACOLOGY

Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats

(2013) Asmaa I. Matouk et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity

(2013) Ahmed M. Al-Abd et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation

(2013) Mona F. Mahmoud et al.   PLoS One

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

(2012) Oktay Tacar et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells

(2011) Davide Staedler et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation

(2011) Bing Sun et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

(2011) Jing Xiao et al.   TOXICOLOGY

Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells

(2010) Shu-Qi Wang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Quercetin and Cancer Chemoprevention

(2010) Lara Gibellini et al.   Evidence-based Complementary and Alternative Medicine

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

(2010) Michael S. Ewer et al.   Nature Reviews Cardiology

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

(2009) Yi-Wei Zhang et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicityThis article is one of a selection of papers published in a special issue celebrating the 125th anniversary of the Faculty of Medicine at the University of Manitoba.

(2009) Ana R. Lehenbauer Ludke et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells

(2009) Gangjun Du et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines

(2008) Shailendra Verma et al.   CANCER TREATMENT REVIEWS

Health effects of quercetin: From antioxidant to nutraceutical

(2008) Agnes W. Boots et al.   EUROPEAN JOURNAL OF PHARMACOLOGY